This inventor holds 5 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1977-1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1977-1980
Title: Gisela Schopflin: Innovator in Pharmaceutical Compositions
Introduction
Gisela Schopflin is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 5 patents to her name, her work has had a substantial impact on medical treatments.
Latest Patents
Among her latest patents is a groundbreaking formulation for a drug excipient made from silicone rubber. This invention involves nontoxic sustained release pharmaceutical compositions that contain one or more nonionic, lipophilic drugs. These compositions are prepared without toxic vulcanizing agents or drug-reactive by-products, ensuring safety and efficacy. The curing process utilizes a noble metal-based catalyst, resulting in compositions that exhibit excellent physical properties and a consistent rate of drug release over extended periods. Another notable patent is the development of a composite vaginal ring that contains a safe and effective amount of a pharmaceutically active medicament.
Career Highlights
Gisela Schopflin has been associated with Schering Aktiengesellschaft, a leading pharmaceutical company. Her work has focused on creating innovative solutions that enhance drug delivery and patient care. Her contributions have been recognized within the industry, establishing her as a key figure in pharmaceutical innovation.
Collaborations
Throughout her career, Gisela has collaborated with esteemed colleagues such as Gerhard Laudahn and Barbara Muhe. These partnerships have fostered a collaborative environment that has led to the advancement of her research and inventions.
Conclusion
Gisela Schopflin's work exemplifies the spirit of innovation in the pharmaceutical industry. Her patents reflect a commitment to improving drug delivery systems and patient outcomes. Through her contributions, she continues to shape the future of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile